ACIU logo

ACIU
AC Immune SA

3,846
Mkt Cap
$283.95M
Volume
357,191.00
52W High
$4.00
52W Low
$1.60
PE Ratio
-3.40
ACIU Fundamentals
Price
$2.79
Prev Close
$2.80
Open
$2.84
50D MA
$2.96
Beta
1.03
Avg. Volume
265,627.50
EPS (Annual)
-$0.8419
P/B
5.01
Rev/Employee
$35,264.75
$206.71
Loading...
Loading...
News
all
press releases
AC Immune (ACIU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
AC Immune (ACIU) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks·2d ago
News Placeholder
More News
News Placeholder
AC Immune CEO Andrea Pfeifer To Retire, Board Chair Martin Z gel To Be Interim CEO
(RTTNews) - Tuesday, AC Immune SA (ACIU) announced that Chief Executive Officer Andrea Pfeifer has decided to retire from her role at the upcoming Annual General Meeting to spend more time with her...
Nasdaq News: Markets·5d ago
News Placeholder
HC Wainwright Has Positive View of AC Immune FY2027 Earnings
AC Immune (NASDAQ:ACIU - Free Report) - Stock analysts at HC Wainwright raised their FY2027 earnings estimates for shares of AC Immune in a report issued on Monday, May 4th. HC Wainwright analyst A...
MarketBeat·11d ago
News Placeholder
BTIG Research Reaffirms "Buy" Rating for AC Immune (NASDAQ:ACIU)
BTIG Research restated a "buy" rating and set a $8.00 price objective on shares of AC Immune in a research report on Monday...
MarketBeat·13d ago
News Placeholder
AC Immune (NASDAQ:ACIU) Announces Earnings Results
AC Immune (NASDAQ:ACIU - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of...
MarketBeat·16d ago
News Placeholder
AC Immune (ACIU) Reports Q1 Loss, Tops Revenue Estimates
AC Immune (ACIU) delivered earnings and revenue surprises of +5.00% and +42.82%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
AC Immune (ACIU) to Release Quarterly Earnings on Wednesday
AC Immune (NASDAQ:ACIU) will be releasing its Q1 2026 earnings before the market opens on Wednesday, April 29. (View Earnings Report at...
MarketBeat·25d ago
News Placeholder
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know
AC Immune stock gains after expansion of its agreement with LLY, adding next-generation Tau Morphomer candidates and boosting long-term Alzheimer's strategy.
Zacks·1mo ago
News Placeholder
Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?
Here is how AC Immune (ACIU) and Assertio (ASRT) have performed compared to their sector so far this year.
Zacks·1mo ago
News Placeholder
AC Immune Amends Morphomer Tau Agreement With Lilly
(RTTNews) - AC Immune SA (ACIU) said Tuesday it has agreed with Eli Lilly and Company (LLY) to amend their 2018 license and collaboration agreement to advance Tau aggregation inhibitor small molecules for the treatment of Alzheimer's disease and other neurodegenerative disorders...
Nasdaq News: Markets·1mo ago
<
1
2
...
>

Latest ACIU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.